Sun Pharma says obesity drugs to be new growth driver for pharma industry We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Use weight reducing drugs judiciously: Dr Jitendra Singh We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Eli Lilly‘s weight-loss therapy Mounjaro became India’s top-selling drug by value in October, data showed on Friday, overtaking GSK’s widely used antibiotic Augmentin, as demand surges in the world’s most populous nation. The U.S. drugmaker’s popular injectable therapy raked in 1 billion rupees ($11.38 million) in October, research firm Pharmarack said. That outpaced Augmentin sales…
Mumbai: Eli Lilly‘s breakthrough weight-loss and diabetes drug Mounjaro has stunned the Indian pharmaceutical market, rising to the no. 2 position in sales within six months of its launch – a feat rarely seen in recent pharma history. Mounjaro posted sales of βΉ80 crore in September, closely trailing the legacy antibiotic brand Augmentin (βΉ85 crore)…
Wegovy-maker Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, the company said on Wednesday. The company is battling competition from copycat versions of its blockbuster Wegovy obesity drug this year and could face layoffs as it battles rising pressure from its main rival Eli Lilly….